BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 2987091)

  • 21. [Corticotropin releasing factor as an aid in the diagnosis of Cushing syndrome].
    Pirich K; Vierhapper H; Nowotny P
    Wien Klin Wochenschr; 1985 Nov; 97(21):806-8. PubMed ID: 2998101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Responses of plasma adrenocorticotropin and cortisol to intravenous injection of synthetic ovine corticotropin releasing factor in the morning and early evening in normal human subjects.
    Watabe T; Tanaka K; Hasegawa M; Miyabe S; Shimizu N
    Endocrinol Jpn; 1985 Oct; 32(5):771-9. PubMed ID: 3004929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
    Lee TI; Lin SY; Won JG; Tang KT; Jap TS; Kwok CF; Lin HD
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct; 65(10):474-82. PubMed ID: 12523812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease.
    Dickstein G; DeBold CR; Gaitan D; DeCherney GS; Jackson RV; Sheldon WR; Nicholson WE; Orth DN
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2934-41. PubMed ID: 8768855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic interaction of corticotropin releasing factor and arginine vasopressin on adrenocorticotropin and cortisol secretion in Macaca fuscata.
    Hashimoto K; Murakami K; Hattori T; Ota Z
    Acta Med Okayama; 1984 Jun; 38(3):261-7. PubMed ID: 6087620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corticotropin-releasing factor in humans. II. CRF stimulation in patients with diseases of the hypothalamo-pituitary-adrenal axis.
    Müller OA; Stalla GK; von Werder K
    Horm Res; 1987; 25(4):185-98. PubMed ID: 3034758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corticotropin releasing factor: a new tool for the differential diagnosis of Cushing's syndrome.
    Müller OA; Stalla GK; von Werder K
    J Clin Endocrinol Metab; 1983 Jul; 57(1):227-9. PubMed ID: 6304135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome.
    Newell-Price J; Perry L; Medbak S; Monson J; Savage M; Besser M; Grossman A
    J Clin Endocrinol Metab; 1997 Jan; 82(1):176-81. PubMed ID: 8989255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma ACTH-response to the corticotropin releasing factor in patients with Cushing's disease. Comparison with the lysine-vasopressin test.
    Catania A; Cantalamessa L; Orsatti A; Mosca G; Minonzio F; Motta P; Reschini E; Zanussi C
    Metabolism; 1984 May; 33(5):478-81. PubMed ID: 6325850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma.
    Arvat E; Giordano R; Ramunni J; Arnaldi G; Colao A; Deghenghi R; Lombardi G; Mantero F; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4207-11. PubMed ID: 9851753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of cortisol, vasopressin (AVP), and corticotropin-releasing factor administration on pulsatile adrenocorticotropin, alpha-melanocyte-stimulating hormone, and AVP secretion in the pituitary venous effluent of the horse.
    Livesey JH; Donald RA; Irvine CH; Redekopp C; Alexander SL
    Endocrinology; 1988 Aug; 123(2):713-20. PubMed ID: 2840266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of corticotropin-releasing factor and other materials on adrenocorticotropin secretion from pituitary glands of patients with Cushing's disease in vitro.
    Suda T; Tomori N; Tozawa F; Demura H; Shizume K
    J Clin Endocrinol Metab; 1984 Nov; 59(5):840-5. PubMed ID: 6148354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early postoperative evaluation in patients with Cushing's disease: usefulness of ovine corticotropin-releasing hormone test in the prediction of recurrence of disease.
    Vignati F; Berselli ME; Loi P
    Eur J Endocrinol; 1994 Mar; 130(3):235-41. PubMed ID: 8156095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Responsivity of adrenocorticotropin to corticotropin-releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease.
    Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
    J Clin Endocrinol Metab; 1986 Apr; 62(4):634-9. PubMed ID: 3005353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human corticotropin-releasing hormone test in patients with hypothalamo-pituitary-adrenocortical disorders.
    Fukata J; Shimizu N; Imura H; Hibi I; Tanaka K; Tanaka T; Nakagawa S; Takebe K; Kimura K; Yoshinaga K
    Endocr J; 1993 Oct; 40(5):597-606. PubMed ID: 7951526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of synthetic ovine corticotropin-releasing factor: prolonged duration of action and biphasic response of plasma adrenocorticotropin and cortisol.
    DeBold CR; DeCherney GS; Jackson RV; Sheldon WR; Alexander AN; Island DP; Rivier J; Vale W; Orth DN
    J Clin Endocrinol Metab; 1983 Aug; 57(2):294-8. PubMed ID: 6306038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo and in vitro ACTH response to ovine corticotropin-releasing factor in a bronchial carcinoid from a patient with ectopic ACTH syndrome.
    Kubo M; Nakagawa K; Akikawa K; Ishizuka T; Matsubara M
    Endocrinol Jpn; 1985 Aug; 32(4):577-81. PubMed ID: 3002773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ACTH and cortisol responses to ovine corticotrophin-releasing factor in patients with primary and secondary adrenal failure.
    Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
    Clin Endocrinol (Oxf); 1985 Jun; 22(6):761-9. PubMed ID: 2990763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.